Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Frontiers in Neurology|March 22, 2014
Hedonic deficits in Parkinson's disease: is consummatory anhedonia specific?Gwenolé Loas, Cécile Duru, Olivier Godefroy, et al.Clinical Therapeutics|October 9, 2008
Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic strokeJean-Marc Bugnicourt, Cécile Duru, Candice Picard, et al.Neuropsychology|March 27, 2013
Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disordersPauline Narme, Harold Mouras, Martine Roussel, et al.Scientific Reports|November 29, 2025
Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern FranceSimon Galmiche, Laurie Pinaud, Laura Tondeur, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 22, 2023
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021Tom Woudenberg, Laurie Pinaud, Laura Garcia, et al.Neurobiology of Disease|July 14, 2009
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's diseaseClaire-Marie Dhaenens, Sylvie Burnouf, Clémence Simonin, et al.Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.Neurobiology of Disease|June 5, 2013
Association between caffeine intake and age at onset in Huntington's diseaseClémence Simonin, Cécile Duru, Julia Salleron, et al.Pageof 1